Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.
Kidney Int
; 79(6): 678-685, 2011 Mar.
Article
in En
| MEDLINE
| ID: mdl-21178977
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Dexamethasone
/
Glomerulosclerosis, Focal Segmental
/
Immunosuppressive Agents
/
Mycophenolic Acid
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Kidney Int
Year:
2011
Type:
Article